中文

Core Directors

current location: Home / People / Core Directors / 正文

Jian He

Date:2019-11-25 show:

undefined Jian He, Ph.D., Associate Professor

 Director of Genomics Core,

 The Center for Single-Cell Omics (CSCOmics), School of Public Health,

 Shanghai Jiao Tong University School of Medicine

 Address: 227 South Chongqing Road, Shanghai, China

 Email: jih003@sjtu.edu.cn





Dr. He obtained her Ph.D. degree from a joint Ph.D. program in Jilin  University and University of California, San Diego, which was supported  by China Scholarship Council. Dr. He then worked in Los Alamos National  Laboratory in the United States, Chinese Academy of Sciences and  Shanghai Jiao Tong University in China. In 2019, Dr. He joined the  Center for Single-Cell Omics in Shanghai Jiao Tong University School of  Medicine as the core director of the genomics core.

Dr. He research focused on developing more sophisticated protocols of  single-cell multiple-omics, and studying major diseases, especially  oncology using single-cell omics strategies. Dr. He has authored more  than 40 high-quality scholarly articles including twelve first-authored  and correspondence author papers, including Genome Research,  EBioMedicine, Scientific Reports, which has been extensively cited.  Also, Dr. He has filed 6 patents (2 issued). She was invited to  contribute review articles by high influential research journals in her  field and give oral presentations at national and international  conferences. Dr. He also serves as an article reviewer of numerous  notable international journals. Dr. He has been awarded research grants  and awards from National Natural Science Foundation, China Postdoctoral  Science Special Foundation, and so on.



Selected Publications:

1. Jian He#, et al. International Journal of Environmental Research and Public Health. Accepted.

2. Jian He#,  et al. Construction of a human cell landscape of COVID-19 Infection at  single-cell level [Abstract]. In: Proceedings of the AACR Virtual  Meeting: COVID-19 and Cancer; 2021 Feb 3-5. Philadelphia (PA): AACR; Clin Cancer Res 2021;27(6_Suppl):Abstract nr P42.

3. Jian He#, et al. Journal of Clinical and Translational Hepatology. Accepted.

4. Jian He, et al. Aging and disease. 2021, 12, 5.

5. Jian He#, et al. MedComm. 2021;1-13.

6. Jian He, et al. Chem Biodivers. 2019 Sep;16(9):e1900176.

7. Jian He, et al. Preprint BioRxiv. doi: https://doi.org/10.1101/ 731935

8. Jian He, et al. EBioMedicine. 2016 Oct;12:4-5.

9. Jian He. Current organic chemistry. 2017, 21(19): 1-22.

10. Jian He, et al. Recurrent somatic mutations of PRKAR1A in isolated cardiac myxoma. Oncotarget. 2017 Nov 28; 8(61): 103968–103974.

11. Jian He. Scientific Reports, 2017 Aug 21;7(1):8867.

12. Xinyu Hu, Yidi Qu, Qiubo Chu, Wenshu Li, Jian He#. Molecular Medicine Reports, 2018,17: 3599-3606.

13. Jian He, et al. Organic Process Research & Development. 2016, 20 (6), pp 1093–1096.

14. Jian He, et al. BioTechniques. 2016; 60 (3):129-135.

15. Jian He, et al. American Journal of Chinese Medicine. 2015, 25:1-13.

16. Jian He, et al. Metabolomics 2015 (5): 159.

17. Jian He, et al. Molecules. 2013; 18 (1):1-13.



Issued Patents:

1. Application of a combination of mTOR kinase inhibitor and MAPK kinase inhibitor. ZL 201510828267.4;

2. Application of a histamine H1 receptor antagonist and its screening method. ZL 201510612612.0.





Core members:

-Director: Jian He

-Technician: Mei Meng

-Technician: Xianchao Zhou